IMPACT OF SEROPOSITIVITY ON DRUG RETENTION OF BIOLOGICS AND JAK INHIBITORS -THE ANSWER COHORT STUDY

被引：0
|
作者：
Etani, Y. [1 ]
Ebina, K. [2 ]
Okita, Y. [3 ]
Maeda, Y. [3 ]
Tsujimoto, K. [3 ]
Onishi, A. [4 ]
Onizawa, H. [4 ]
Okano, T. [5 ,9 ]
Nishimura, K. [5 ]
Yoshikawa, A. [6 ]
Shiba, H. [6 ]
Amuro, H. [7 ]
Son, Y. [7 ]
Hashimoto, M. [8 ]
Okano, T. [5 ,9 ]
Hara, R. [10 ]
Yamamoto, W. [11 ]
Kumanogoh, A. [3 ]
Okada, S. [1 ]
机构：
[1] Osaka Univ, Grad Sch Med, Dept Orthopaed Surg, Osaka, Japan
[2] Osaka Univ, Grad Sch Med, Dept Musculoskeletal Regenerat Med, Osaka, Japan
[3] Osaka Univ, Grad Sch Med, Dept Resp Med & Clin Immunol, Osaka, Japan
[4] Kyoto Univ, Grad Sch Med, Dept Adv Med Rheumat Dis, Kyoto, Japan
[5] Kobe Univ, Dept Rheumatol & Clin Immunol, Grad Sch Med, Kobe, Japan
[6] Osaka Med & Pharmaceut Univ, Dept Internal Med 4, Osaka, Japan
[7] Kansai Med Univ, Dept Internal Med 1, Osaka, Japan
[8] Osaka Metropolitan Univ, Grad Sch Med, Dept Clin Immunol, Osaka, Japan
[9] Osaka Metropolitan Univ, Grad Sch Med, Dept Orthoped Surg, Osaka, Japan
[10] Nara Med Univ, Dept Orthopaed Surg, Nara, Japan
[11] Kurashiki Sweet Hosp, Dept Hlth Informat Management, Kurashiki, Japan
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
bDMARD; Rheumatoid arthritis; Biomarkers;
D O I：
10.1136/annrheumdis-2023-eular.1114
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0407
引用
收藏
页码：1389 / 1389
页数：1
相关论文
共 50 条
  • [1] DRUG RETENTION AND REASONS FOR DISCONTINUATION OF BIOLOGICS AND JAK INHIBITORS IN PATIENTS WITH RHEUMATOID ARTHRITIS - THE ANSWER COHORT STUDY
    Ebina, K.
    Etani, Y.
    Maeda, Y.
    Okita, Y.
    Hirao, M.
    Yamamoto, W.
    Hashimoto, M.
    Murata, K.
    Hara, R.
    Nagai, K.
    Hiramatsu, Y.
    Son, Y.
    Amuro, H.
    Fujii, T.
    Okano, T.
    Ueda, Y.
    Katayama, M.
    Okano, T.
    Kumanogoh, A.
    Okada, S.
    Nakata, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 234 - 235
  • [2] Drug retention of secondary biologics or JAK inhibitors after tocilizumab or abatacept failure as first biologics in patients with rheumatoid arthritis -the ANSWER cohort study
    Ebina, Kosuke
    Hirano, Toru
    Maeda, Yuichi
    Yamamoto, Wataru
    Hashimoto, Motomu
    Murata, Koichi
    Takeuchi, Tohru
    Nagai, Koji
    Son, Yonsu
    Amuro, Hideki
    Onishi, Akira
    Jinno, Sadao
    Hara, Ryota
    Katayama, Masaki
    Yamamoto, Keiichi
    Kumanogoh, Atsushi
    Hirao, Makoto
    CLINICAL RHEUMATOLOGY, 2020, 39 (09) : 2563 - 2572
  • [3] Drug retention of secondary biologics or JAK inhibitors after tocilizumab or abatacept failure as first biologics in patients with rheumatoid arthritis -the ANSWER cohort study-
    Kosuke Ebina
    Toru Hirano
    Yuichi Maeda
    Wataru Yamamoto
    Motomu Hashimoto
    Koichi Murata
    Tohru Takeuchi
    Koji Nagai
    Yonsu Son
    Hideki Amuro
    Akira Onishi
    Sadao Jinno
    Ryota Hara
    Masaki Katayama
    Keiichi Yamamoto
    Atsushi Kumanogoh
    Makoto Hirao
    Clinical Rheumatology, 2020, 39 : 2563 - 2572
  • [4] DRUG RETENTION OF BIOLOGICS OR JAK INHIBITORS IN PATIENTS WITH DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS: RESULTS FROM THE ANSWER COHORT
    Watanabe, R.
    Okano, T.
    Yamada, S.
    Yamamoto, W.
    Murata, K.
    Murakami, K.
    Ebina, K.
    Maeda, Y.
    Jinno, S.
    Shirasugi, I.
    Son, Y.
    Amuro, H.
    Katayama, M.
    Hara, R.
    Hata, K.
    Yoshikawa, A.
    Hashimoto, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 527 - 528
  • [5] Drug retention of biologics and Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort study
    Ebina, Kosuke
    Etani, Yuki
    Maeda, Yuichi
    Okita, Yasutaka
    Hirao, Makoto
    Yamamoto, Wataru
    Hashimoto, Motomu
    Murata, Koichi
    Hara, Ryota
    Nagai, Koji
    Hiramatsu, Yuri
    Son, Yonsu
    Amuro, Hideki
    Fujii, Takayuki
    Okano, Takaichi
    Ueda, Yo
    Katayama, Masaki
    Okano, Tadashi
    Tachibana, Shotaro
    Hayashi, Shinya
    Kumanogoh, Atsushi
    Okada, Seiji
    Nakata, Ken
    RMD OPEN, 2023, 9 (03):
  • [6] Drug retention of 7 biologics and tofacitinib in biologics-naive and biologics-switched patients with rheumatoid arthritis: the ANSWER cohort study
    Ebina, Kosuke
    Hirano, Toru
    Maeda, Yuichi
    Yamamoto, Wataru
    Hashimoto, Motomu
    Murata, Koichi
    Takeuchi, Tohru
    Shiba, Hideyuki
    Son, Yonsu
    Amuro, Hideki
    Onishi, Akira
    Akashi, Kengo
    Hara, Ryota
    Katayama, Masaki
    Yamamoto, Keiichi
    Kumanogoh, Atsushi
    Hirao, Makoto
    ARTHRITIS RESEARCH & THERAPY, 2020, 22 (01)
  • [7] Disease Duration Differentially Affects the Clinical Efficacy of Biologics and JAK Inhibitors in Rheumatoid Arthritis: The ANSWER Cohort Study
    Nakayama, Yoichi
    Kabata, Daijiro
    Yamamoto, Wataru
    Makino, Hidehiko
    Nagai, Koji
    Yoshida, Naofumi
    Son, Yonsu
    Katayama, Masaki
    Yamada, Hirotaka
    Nishimura, Keisuke
    Hara, Ryota
    Watanabe, Ryu
    Etani, Yuki
    Ebina, Kosuke
    Onizawa, Hideo
    Fujii, Takayuki
    Onishi, Akira
    Murakami, Kosaku
    Murata, Koichi
    Tanaka, Masao
    Matsuda, Shuichi
    Morinobu, Akio
    Shintani, Ayumi
    Hashimoto, Motomu
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 1057 - 1059
  • [8] DRUG RETENTION OF 7 BIOLOGICS AND TOFACITINIB IN BIOLOGICS-NAIVE AND BIOLOGICS-SWITCHED PATIENTS WITH RHEUMATOID ARTHRITIS-THE ANSWER COHORT STUDY
    Ebina, K.
    Hirano, T.
    Maeda, Y.
    Yamamoto, W.
    Hashimoto, M.
    Murata, K.
    Takeuchi, T.
    Shiba, H.
    Son, Y.
    Amuro, H.
    Onishi, A.
    Akashi, K.
    Hara, R.
    Katayama, M.
    Yamamoto, K.
    Kumanogoh, A.
    Hirao, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 18 - 19
  • [9] Drug retention of 7 biologics and tofacitinib in biologics-naïve and biologics-switched patients with rheumatoid arthritis: the ANSWER cohort study
    Kosuke Ebina
    Toru Hirano
    Yuichi Maeda
    Wataru Yamamoto
    Motomu Hashimoto
    Koichi Murata
    Tohru Takeuchi
    Hideyuki Shiba
    Yonsu Son
    Hideki Amuro
    Akira Onishi
    Kengo Akashi
    Ryota Hara
    Masaki Katayama
    Keiichi Yamamoto
    Atsushi Kumanogoh
    Makoto Hirao
    Arthritis Research & Therapy, 22
  • [10] Comparison of drug retention of TNF inhibitors, other biologics and JAK inhibitors in RA patients who discontinued JAK inhibitor therapy
    Amstad, Andrea
    Papagiannoulis, Eleftherios
    Scherer, Almut
    Rubbert-Roth, Andrea
    Finckh, Axel
    Mueller, Ruediger
    Dudler, Jean
    Moeller, Burkhard
    Villiger, Peter M.
    Schulz, Martin M. P.
    Kyburz, Diego
    RHEUMATOLOGY, 2022, 62 (01) : 89 - 97
12345